ARTICLE | Clinical News
Cosentyx secukinumab: Extension study data
October 10, 2016 7:00 AM UTC
Top-line data from 642 patients with moderate to severe plaque psoriasis in the international A2304E1 extension of the double-blind, placebo-controlled, international Phase III SCULPTURE trial showed ...